N1,N2-BIS(5-METHYL-[1,1'-BIPHENYL]-2-YL)OXALAMIDE, 90%, 1g

2-(2-(Phenylamino)phenyl)acetic acid, 98%, 5g

Thymol, min. 99%, 100 g, glass packaging

5-Nitro-1H-benzo[d]imidazole, 95.0%, 25g

3-(CYCLOPENTYLOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-METHOXYBENZAMIDE, 95%, 5mg

1-butyl-4-Nitroso-1H-pyrazol-5-amine hydrochloride, 97.0%, 5g

2-(Furan-3-yl)ethanamine hydrochloride, 95%, 100mg

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-6-carboxylate, 95.0%, 5g

Bromobenzene, 98%, 500g

2-(Bis(2-(2,6-dioxomorpholino)ethyl)amino)acetic acid, 95.0%, 25g

N-(2-Ethyl-4-bromophenyl)-2-chloropropanamide, 95%, 10g

Adamantane (purified by sublimation)>99.5%(GC)5g

4-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 50mg